Identification of cytochrome P450 (CYP) isoforms involved in the metabolism of corynoline, and assessment of its herb–drug interactions
- 1 February 2011
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 25 (2) , 256-263
Abstract
Corynoline, an isoquinoline alkaloid isolated from the genusCorydalis, has been demonstrated to show multiple pharmacological effects including inhibition of acetylcholinesterase, inhibition of cell adhesion, fungitoxic and cytotoxic activity. The present study focused on its metabolism and metabolism‐based herb–drug interactions. After corynoline was incubated with human liver microsomes (HLMs) in the presence of NADPH, two metabolites (M‐1 and M‐2) were formed. Chemical inhibition experiments and assays with recombinant CYP isoforms showed that CYP2C9 was mainly involved in the formation of M‐1 and CYP3A4 mainly catalysed the production of M‐2. Among seven major CYP isoforms tested, corynoline showed strong inhibitory effects on the activities of CYP3A4 and CYP2C9, with an IC50of 3.3 ± 0.9 µmand 31.5 ± 0.5 µm, respectively. Kinetic analysis showed that inhibition of CYP3A4 by corynoline was best fit to a noncompetitive manner withKiof 3.2 µm, while inhibition of CYP2C9 by corynoline was best fit to a competitive manner withKiof 6.3 µm. Additionally, corynoline exhibited time‐dependent inhibition (TDI) toward CYP3A4. The inactivation kinetic parameters (KIandkinact) were calculated to be 6.8 µmand 0.07 min‐1, respectively. These data are of significance for the application of corynoline and corynoline‐containing herbs. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 21 references indexed in Scilit:
- Time‐dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine–warfarin interactionBritish Journal of Clinical Pharmacology, 2010
- Characterization of human cytochrome P450 isoforms involved in the metabolism of 7-epi-paclitaxelXenobiotica, 2009
- Cytochrome P450s in the development of target-based anticancer drugsCancer Letters, 2008
- Identification of drugs that interact with herbs in drug developmentDrug Discovery Today, 2007
- Cytochrome P450s and other enzymes in drug metabolism and toxicityThe AAPS Journal, 2006
- SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKASTDrug Metabolism and Disposition, 2005
- Cell adhesion inhibitory activity of (d)-corynoline, a hexahydrobenzo[c]phenanthridine-type alkaloid, and its structure–activity relationship, studied by X-ray crystal structure analysis and molecular docking studyBioorganic & Medicinal Chemistry, 2005
- Inhibitory effect of stiripentol on clobazam metabolism by cDNA-expressed human CYPClinical Pharmacology & Therapeutics, 2005
- IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACTDrug Metabolism and Disposition, 2004
- Inhibitory effect of corynoline isolated from the aerial parts ofcorydalis incisa on the acetylcholinesteraseArchives of Pharmacal Research, 2002